Aug 5, 2026 07:00AM
Jul 22, 2026 07:05AM
Jul 22, 2026 07:05AM
Mar 2, 2026 06:10AM
Mar 2, 2026 06:01AM
Mar 2, 2026 06:01AM
Feb 11, 2026 07:00AM Royalty Pharma Reports Q4 and Full Year 2025 Results
Dec 12, 2025 10:47AM
Dec 4, 2025 07:10AM
Dec 4, 2025 07:02AM
Dec 4, 2025 07:00AM
Nov 5, 2025 07:00AM
Nov 4, 2025 07:15AM
Nov 4, 2025 07:15AM Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences
Sep 11, 2025 07:00AM
Sep 2, 2025 07:15AM
Sep 2, 2025 07:15AM
Sep 2, 2025 07:05AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:10AM Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
Aug 25, 2025 06:01AM
Aug 25, 2025 06:00AM
Aug 6, 2025 07:00AM
Jul 17, 2025 08:15AM
Jul 17, 2025 08:15AM
May 16, 2025 04:30PM
May 16, 2025 06:12AM Morgan Stanley Reinstates Royalty Pharma (RPRX) at Overweight
May 12, 2025 04:17PM
May 12, 2025 04:15PM
May 12, 2025 04:15PM
May 12, 2025 04:15PM
May 8, 2025 07:15AM
Feb 11, 2025 07:15AM
Jan 29, 2025 09:04AM Royalty Pharma (RPRX) Announces Sale of MorphoSys Development Funding Bonds
Jan 29, 2025 09:00AM
Jan 10, 2025 07:30AM
Jan 10, 2025 07:16AM
Jan 10, 2025 07:15AM
Nov 7, 2024 07:11AM
Nov 7, 2024 07:10AM
Nov 6, 2024 07:15AM Royalty Pharma Reports Third Quarter 2024 Results
Oct 7, 2024 09:28AM
Aug 8, 2024 07:00AM
May 28, 2024 07:10AM
May 28, 2024 07:10AM
May 9, 2024 07:00AM
May 9, 2024 06:45AM
May 9, 2024 06:45AM Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
Feb 15, 2024 07:30AM

1,176,867 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All